D-Mannose
Binds E. coli in urine to prevent bladder wall adhesion — clinically supported for preventing recurrent UTIs without antibiotics.
D-Mannose is a naturally occurring sugar related to glucose that's poorly absorbed and largely excreted in urine. This property makes it ideal for UTI prevention — it binds to E. coli bacteria (which cause 80-90% of UTIs) and prevents them from adhering to the bladder wall. Clinical evidence supports its use for preventing recurrent UTIs, particularly in women.
Binds to E. coli fimbriae, preventing attachment
Bacteria-mannose complexes are flushed out with urination
How D-Mannose works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
2g daily for prevention; 1.5-2g every 2-3 hours for acute symptoms
Loading: For acute UTI symptoms: 2g immediately, then 2g every 2-3 hours for 3 days
Can be taken without food
| Form | Type |
|---|---|
| 🧪Pure D-Mannose powder | Recommended |
| 💊Capsules | Alternative |
| 💊Combined with cranberry | Alternative |
Powder is most economical for acute treatment. Tastes mildly sweet.
Minimum: 1 days
Optimal: 2 days
Cycling: Not required
Note: Best taken on empty stomach with full glass of water. Taking before bed allows longer contact time in bladder.
Significantly fewer recurrent UTIs
May help at first sign of UTI
Likely safe; preferable to antibiotics when appropriate
Monitor blood sugar; most D-mannose is not absorbed
May theoretically affect blood sugar; most is excreted unabsorbed
Tip: Reduce dose
Tip: Normal osmotic effect at high doses
Top studies from 38+ peer-reviewed papers
Han Z et al. • Infection (2025)
“D-mannose, triple therapy, vaccine, probiotics, and cranberry serve as potential nonantibiotic intervention options for clinical UTI prevention.”
Vargas CEF et al. • Jornal brasileiro de nefrologia (2025)
“In this meta-analysis of RCTs, D-mannose did not reduce the incidence of recurrent UTIs compared with control or antibiotics in high-risk patients.”
Hayward G et al. • JAMA internal medicine (2024)
“In this randomized clinical trial, daily d-mannose did not reduce the proportion of women with recurrent UTI in primary care who experienced a subsequent clinically suspected UTI. d-Mannose should not be recommended for prophylaxis in this patient group.”
Chen YC et al. • International journal of molecular sciences (2023)
“Additional clinical trials are warranted to validate the therapeutic efficacy and durability of these techniques.”
Cooper TE et al. • The Cochrane database of systematic reviews (2022)
“There is currently little to no evidence to support or refute the use of D-mannose to prevent or treat UTIs in all populations.”
What would you like to do next?
Luteolin
8.5/10Crosses the blood-brain barrier to reduce neuroinflammation and inhibits mast cell activation — useful for allergies and brain health.
Beta-Glucans
8/10Polysaccharides from yeast, mushrooms, or oats that train innate immune cells to respond faster to infections and pathogens.
Propolis
8/10CAPE-rich bee resin with broad antimicrobial and antiviral activity — supports respiratory infections, wound healing, and oral health.
Quercetin
8/10Flavonoid with senolytic and anti-inflammatory properties — supports immune defense, allergy relief, and exercise performance.
Tap node to isolate • Pinch to zoom • Tap edge for research